← Open Payments lookup

AMY CHANDLER: Open Payments

NPI 1205266723 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$254 in 11 payments from 8 companies in 2025. Trend: 2023 $535 · 2024 $450 · 2025 $254

Food & beverage: $254
CompanyPaymentsAmount
Regeneron Healthcare Solutions, Inc.2$55
AstraZeneca Pharmaceuticals LP2$45
United Therapeutics Corporation2$42
Takeda Pharmaceuticals U.S.A., Inc.1$34
Actelion Pharmaceuticals US, Inc.1$25
Mallinckrodt Hospital Products Inc.1$24
Baxter Healthcare1$23
3B Medical, Inc.1$7

Products named: DUPIXENT, Tyvaso, GLASSIA, OPSYNVI, ACTHAR, TEZSPIRE, Fluid Systems - Premix Drugs, FASENRA.

Industry payments across MD — which companies pay providers there.